1-4 of 4
Jan-Dirk Banga
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Common Cholesteryl Ester Transfer Protein Gene Polymorphisms and the Effect of Atorvastatin Therapy in Type 2 Diabetes

Free
Francine V. van Venrooij, MD, PHD, Ronald P. Stolk, PHD, Jan-Dirk Banga, MD, PHD, Tjeerd P. Sijmonsma, Arie van Tol, PHD, D. Willem Erkelens, MD, PHD, Geesje M. Dallinga-Thie, PHD, for the DALI study group
Journal: Diabetes Care
Diabetes Care 2003;26(4):1216–1223
https://doi.org/10.2337/diacare.26.4.1216
Published: 01 April 2003
View articletitled, Common Cholesteryl Ester Transfer Protein Gene Polymorphisms and the Effect of Atorvastatin Therapy in Type 2 Diabetes
Open the PDF for Common Cholesteryl Ester Transfer Protein Gene Polymorphisms and the Effect of Atorvastatin Therapy in Type 2 Diabetes in another window
Journal Articles

Plasma Levels of Cellular Fibronectin in Diabetes

Free
Suzan D.J.M. Kanters, MD, PHD, Jan-Dirk Banga, MD, PHD, Ale Algra, MD, PHD, Rini C.J.M. Frijns, MD, Jaap J. Beutler, MD, PHD, Rob Fijnheer, MD, PHD
Journal: Diabetes Care
Diabetes Care 2001;24(2):323–327
https://doi.org/10.2337/diacare.24.2.323
Published: 01 February 2001
View articletitled, Plasma Levels of Cellular Fibronectin in Diabetes
Open the PDF for Plasma Levels of Cellular Fibronectin in Diabetes in another window
Journal Articles

Carotid Intima-Media Thickness in Hyperlipidemic Type I and Type II Diabetic Patients

Free
Suzan D J M Kanters, MD, Ale Algra, MD, Jan-Dirk Banga, MD
Journal: Diabetes Care
Diabetes Care 1997;20(3):276–280
https://doi.org/10.2337/diacare.20.3.276
Published: 01 March 1997
View articletitled, Carotid Intima-Media Thickness in Hyperlipidemic Type I and Type II Diabetic Patients
Open the PDF for Carotid Intima-Media Thickness in Hyperlipidemic Type I and Type II Diabetic Patients in another window
Journal Articles

Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet and Vessel Wall Interaction in NIDDM

Free
H Tineke Westerveld, MD, Jacques C de Graaf, MD, Hans HFI Van Breugel, PHD, Jan Willem N Akkerman, PHD, Jan J Sixma, MD, PHD, D Willem Erkelens, MD, PHD, Jan Dirk Banga, MD, PHD
Journal: Diabetes Care
Diabetes Care 1993;16(5):683–688
https://doi.org/10.2337/diacare.16.5.683
Published: 01 May 1993
View articletitled, Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet and Vessel Wall Interaction in NIDDM
Open the PDF for Effects of Low-Dose EPA-E on Glycemic Control, Lipid Profile, Lipoprotein(a), Platelet Aggregation, Viscosity, and Platelet and Vessel Wall Interaction in NIDDM in another window